Given that miR-342 directly targets IA-2 as previously demonstrated in the insulin-containing MIN6 cells by “RNA immunoprecipitation PCR with anti-argonaute 2” [25], the impact of miR-342 on SCLC cell proliferation was evaluated. This evidence concerns the gene PTPRN and small cell lung carcinoma.